Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders


Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function

Volume:11   Issue: 4
Pp: 262-272
Claire F. Jessup, Claudine S. Bonder, Stuart M. Pitson and P. Toby H. Coates
DOI: 10.2174/187153011797881201

The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications

Volume:11   Issue: 4
Pp: 273-284
Elisa Benetti, Nimesh S.A. Patel and Massimo Collino
DOI: 10.2174/187153011797881175

Ovulation, Implantation and Placentation in Females with Obesity and Metabolic Disorders: Life in the Balance

Volume:11   Issue: 4
Pp: 285-301
Antonio Gonzalez-Bulnes, Pilar Pallares and Cristina Ovilo
DOI: 10.2174/187153011797881193

FGF10 and FGF21 as Regulators in Adipocyte Development and Metabolism

Volume:11   Issue: 4
Pp: 302-309
Hiroya Ohta, Morichika Konishi and Nobuyuki Itoh
DOI: 10.2174/187153011797881166

Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator

Volume:11   Issue: 4
Pp: 326-333
Federica Laudisi, Manolo Sambucci and Claudio Pioli
DOI: 10.2174/187153011797881184

The Regulation of FoxP3-Expressing Regulatory T Cells

Volume:11   Issue: 4
Pp: 334-346
Rizwanul Haque, Fengyang Lei, Xiaofang Xiong and Jianxun Song
DOI: 10.2174/187153011797881157